The regimen based on trimethoprim/sulfamethoxazole combination of caspofungin and corticosteroids as the first-line therapy for non-HIV patients with severe pneumocystis jirovecii pneumonia：a retrospective research of a tertiary hospital
Research Square (Research Square)